Cargando…

Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis

Objective: Antipsychotic medication non-adherence has detrimental effects on patients' clinical outcome. It is unclear which risk factors affect adherence most and which interventions are effective at improving adherence to antipsychotic medication. The aim of this systematic review is to summa...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Abdellati, Kawtar, De Picker, Livia, Morrens, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584050/ https://www.ncbi.nlm.nih.gov/pubmed/33162877 http://dx.doi.org/10.3389/fnins.2020.531763

Ejemplares similares

Perspective: Solving the Heterogeneity Conundrum of TSPO PET Imaging in Psychosis
por: De Picker, Livia, et al.
Publicado: (2020)

Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium
por: El Abdellati, Kawtar, et al.
Publicado: (2021)

Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
por: De Picker, Livia J., et al.
Publicado: (2017)

Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
por: Wessa, Céline, et al.
Publicado: (2023)

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure
por: Downs, Johnny, et al.
Publicado: (2019)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
por: Mousavi, Seyed Ghafur, et al.
Publicado: (2013)

Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
por: Skorobogatov, Katrien, et al.
Publicado: (2021)

Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population
por: Alene, Menna, et al.
Publicado: (2012)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

Patients with psychosis spectrum disorders hospitalized during the COVID-19 pandemic unravel overlooked SARS-CoV-2 past infection clustering with HERV-W ENV expression and chronic inflammation
por: Tamouza, Ryad, et al.
Publicado: (2023)

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease
por: Divac, Nevena, et al.
Publicado: (2016)

Interventions to Improve Medication Adherence in Patients with Schizophrenia or Bipolar Disorders: A Systematic Review and Meta-Analysis
por: Loots, Elke, et al.
Publicado: (2021)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
por: Plavén-Sigray, Pontus, et al.
Publicado: (2020)

Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis
por: Titus-Lay, Erika N., et al.
Publicado: (2018)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016)

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
por: Moncrieff, Joanna, et al.
Publicado: (2020)

Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
por: Raben, Alex T., et al.
Publicado: (2018)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
por: Hebbrecht, Kaat, et al.
Publicado: (2021)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
por: Ye, Jiaen, et al.
Publicado: (2019)

Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
por: Thompson, Andrew, et al.
Publicado: (2018)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis
por: Jethwa, Ketan Dipak, et al.
Publicado: (2015)

PDE10A Inhibitors—Clinical Failure or Window Into Antipsychotic Drug Action?
por: Menniti, Frank S., et al.
Publicado: (2021)

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

Antipsychotics are related to psychometric conversion to psychosis in ultra‐high‐risk youth
por: Preti, Antonio, et al.
Publicado: (2021)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
por: Zaremba, Malgorzata, et al.
Publicado: (2023)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
por: Dayabandara, Madhubhashinee, et al.
Publicado: (2017)

The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders
por: Abdullah-Koolmees, H., et al.
Publicado: (2021)

Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia
por: Mizoguchi, Yoshito, et al.
Publicado: (2014)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2019)

Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
por: Lian, Lulu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ca8n8q12kda5ridj6vet6c594